Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

17 Jun 2020

Abstract excerpt

Abstract Purpose: Gene expression–based molecular subtypes of high-grade serous tubo-ovarian cancer (HGSOC), demonstrated across multiple studies, may provide improved stratification for molecularly targeted trials. However, evaluation of clinical utility has been hindered by nonstandardized methods, which are not applicable in a clinical setting. We sought to generate a clinical grade minimal gene set assay for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32554541
DOI: 10.1158/1078-0432.ccr-20-0103

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)PMID 32554541Read ↗

Efficient molecular subtype classification of high‐grade serous ovarian cancerSemantic proximity Read ↗

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Consensus on Molecular Subtypes of Ovarian CancerSemantic proximity Read ↗

Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinomaSemantic proximity Read ↗

Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironmentSemantic proximity Read ↗

Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian CarcinomaSemantic proximity Read ↗

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.Semantic proximity Read ↗

Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.Semantic proximity Read ↗

Ovarian cancer and the evolution of subtype classifications using transcriptional profiling†Semantic proximity Read ↗

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategiesSemantic proximity Read ↗

The molecular prognostic score , a classifier for risk stratification of high-grade serous ovarian cancerSemantic proximity Read ↗

The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.